Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)
- PMID: 33992496
- DOI: 10.1016/j.rmed.2021.106436
Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI)
Abstract
Introduction: The Borg and Modified Medical Research Council (mMRC) dyspnea scales have been used to evaluate dyspnea in sarcoidosis. The Baseline Dyspnea Index (BDI) and Transitional Dyspnea Index (TDI) are useful for the assessment of dyspnea in COPD. It is not known if the BDI-TDI accurately assesses dyspnea in sarcoidosis patients.
Methods: Data was analyzed from the Registry for Advanced Sarcoidosis (ReAS), a multi-national database enrolling patients with advanced sarcoidosis and a comparison group of sarcoidosis patients with non-advanced disease. At baseline, patients completed a BDI questionnaire along with spirometry, 6-min walk distance (6MWD), mMRC, Borg score, fatigue assessment score (FAS) and HRQoL assessments using Kings Sarcoidosis Questionnaire (KSQ) and St Georges Respiratory Questionnaire (SGRQ). At 12-months, patients with advanced disease completed a TDI questionnaire along with the other measures. Correlations between BDI and baseline variables, and between TDI and changes in baseline variables were evaluated.
Results: There was significant correlation (p < 0.001 for all) between BDI and baseline 6MWD (rho = 0.336), FVC% (rho = 0.387), FEV1% (rho = 0.285), DLCO% (rho = 0.355), mMRC (rho = -0.721), Borg score (rho = -0.389), FAS (rho = -0.669), SGRQ (rho = -0.785), and KSQ (rho = 0.318 to 0.724). At follow-up, TDI correlated with BDI, but not with changes in pulmonary function or other dyspnea measures.
Conclusion: BDI scores correlated with pulmonary function, 6MWD, and other dyspnea measures. TDI scores did not correlate with changes in pulmonary function or other dyspnea measures. BDI may be a useful independent measure of dyspnea in sarcoidosis patients. The role of TDI needs further evaluation in longitudinal studies associated with changes in clinical parameters.
Keywords: Baseline dyspnea index; Dyspnea; Health related quality of life; Sarcoidosis; Transitional dyspnea index.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
[Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].Nan Fang Yi Ke Da Xue Xue Bao. 2021 Jul 20;41(7):1119-1124. doi: 10.12122/j.issn.1673-4254.2021.07.23. Nan Fang Yi Ke Da Xue Xue Bao. 2021. PMID: 34308866 Free PMC article. Chinese.
-
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015. Int J Chron Obstruct Pulmon Dis. 2015. PMID: 26316740 Free PMC article.
-
Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.Chest. 2002 Apr;121(4):1092-8. doi: 10.1378/chest.121.4.1092. Chest. 2002. PMID: 11948037 Clinical Trial.
-
[Ways to quantify dyspnea severity. Part I. Baseline Dyspnea Index (BDI), Transition Dyspnea Index (TDI)].Pneumologia. 2006 Apr-Jun;55(2):58-63. Pneumologia. 2006. PMID: 17069203 Review. Romanian.
-
The MCID of the transition dyspnea index is a total score of one unit.COPD. 2005 Mar;2(1):99-103. doi: 10.1081/copd-200050666. COPD. 2005. PMID: 17136969 Review.
Cited by
-
The Symptoms of Pulmonary Sarcoidosis.J Clin Med. 2023 Sep 20;12(18):6088. doi: 10.3390/jcm12186088. J Clin Med. 2023. PMID: 37763028 Free PMC article. Review.
-
Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.Mini Rev Med Chem. 2024;24(6):618-633. doi: 10.2174/1389557523666230816090112. Mini Rev Med Chem. 2024. PMID: 37587813 Review.
-
Health-related quality of life in cardiac sarcoidosis: a systematic review.Eur Heart J Open. 2023 Feb 18;3(2):oead009. doi: 10.1093/ehjopen/oead009. eCollection 2023 Mar. Eur Heart J Open. 2023. PMID: 36974155 Free PMC article. Review.
-
Novel biomarkers for the assessment of disease activity in patients with sarcoidosis: a case-control study.Sarcoidosis Vasc Diffuse Lung Dis. 2023 Jun 29;40(2):e2023017. doi: 10.36141/svdld.v40i2.14327. Sarcoidosis Vasc Diffuse Lung Dis. 2023. PMID: 37382070 Free PMC article.
-
Shortness of Breath on Day 1 After Surgery Alerting the Presence of Early Respiratory Complications After Surgery in Lung Cancer Patients.Patient Prefer Adherence. 2022 Mar 19;16:709-722. doi: 10.2147/PPA.S348633. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35340757 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous